WallStSmart

Doximity Inc (DOCS)vsHinge Health, Inc. (HNGE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hinge Health, Inc. generates 1% more annual revenue ($646.34M vs $637.78M). DOCS leads profitability with a 37.5% profit margin vs -78.9%. DOCS earns a higher WallStSmart Score of 66/100 (B-).

DOCS

Strong Buy

66

out of 100

Grade: B-

Growth: 5.3Profit: 9.0Value: 8.0Quality: 8.3
Piotroski: 6/9Altman Z: 5.72

HNGE

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 3.5Value: 6.0Quality: 5.0
Piotroski: 3/9Altman Z: -2.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DOCSUndervalued (+44.4%)

Margin of Safety

+44.4%

Fair Value

$46.71

Current Price

$25.98

$20.73 discount

UndervaluedFair: $46.71Overvalued
HNGEUndervalued (+23.6%)

Margin of Safety

+23.6%

Fair Value

$50.74

Current Price

$56.02

$5.28 discount

UndervaluedFair: $50.74Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DOCS5 strengths · Avg: 9.4/10
Profit MarginProfitability
37.5%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
38.9%10/10

Strong operational efficiency at 38.9%

Altman Z-ScoreHealth
5.7210/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
23.8%9/10

Every $100 of equity generates 24 in profit

PEG RatioValuation
0.698/10

Growing faster than its price suggests

HNGE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
47.2%10/10

Revenue surging 47.2% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Areas to Watch

DOCS1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
39.5x2/10

Trading at 39.5x book value

Return on EquityProfitability
-136.0%2/10

ROE of -136.0% — below average capital efficiency

EPS GrowthGrowth
-94.4%2/10

Earnings declined 94.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : DOCS

The strongest argument for DOCS centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 37.5% and operating margin at 38.9%. PEG of 0.69 suggests the stock is reasonably priced for its growth.

Bull Case : HNGE

The strongest argument for HNGE centers on Revenue Growth, Debt/Equity. Revenue growth of 47.2% demonstrates continued momentum.

Bear Case : DOCS

The primary concerns for DOCS are EPS Growth.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Key Dynamics to Monitor

DOCS profiles as a mature stock while HNGE is a hypergrowth play — different risk/reward profiles.

HNGE is growing revenue faster at 47.2% — sustainability is the question.

DOCS generates stronger free cash flow (59M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DOCS scores higher overall (66/100 vs 36/100), backed by strong 37.5% margins. HNGE offers better value entry with a 23.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Doximity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

Want to dig deeper into these stocks?